MedEdTalks - Gastroenterology
By Vindico Medical Education
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Vindico Medical Education
Category: Medicine
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 13
Reviews: 0
Episodes: 18
Description
MedEdTalks Gastroenterology is an accredited educational podcast for providers to learn more about treating patients with Gastroenterology diseases/disorders. Discover all content and topics by visiting mededtalks.com.
| Episode | Date |
|---|---|
|
Diet and Targeted Therapy With Drs. Dellon and Hirano
|
May 19, 2023 |
|
Steroids and PPIs in the Treatment of EoE With Drs. Dellon and Beveridge
|
May 19, 2023 |
|
Differential Diagnosis of EoE With Drs. Dellon and Chehade
|
May 19, 2023 |
|
Pearls From the Pros on IBD Management: Anti-Integrin and S1P Receptor Modulation in IBD Practice With Drs. David Rubin and Maria Abreu
|
Jan 06, 2022 |
|
Pearls From the Pros on IBD Management: JAK Inhibition in IBD Practice With Drs. David Rubin and Millie Long
|
Jan 06, 2022 |
|
Pearls From the Pros on IBD Management: Anti-IL-12/23 in IBD Practice With Drs. David Rubin and Bruce Sands
|
Jan 06, 2022 |
|
Pearls From the Pros on IBD Management: Anti-TNF Therapy in IBD Practice With Drs. David Rubin and Stephen Hanauer
|
Jan 06, 2022 |
|
Immunogenicity of Current IBD Biologics With Drs. Edward Loftus and Marla Dubinsky
|
Aug 18, 2021 |
|
Extraintestinal Manifestations of IBD With Drs. Edward Loftus and Miguel Regueiro
|
Aug 18, 2021 |
|
Biologics for IBD – Monotherapy Versus Combination Approaches With Drs. Edward Loftus and Marla Dubinsky
|
Aug 18, 2021 |
|
New Insights on Treat to Target in Moderate to Severe IBD With Drs. Edward Loftus and Miguel Regueiro
|
Aug 18, 2021 |
|
Efficacy and Safety of Anti-interleukin (IL) 23 and Janus Kinase (JAK) Inhibitors with Drs. William J. Sandborn and Jessica R. Allegretti
|
Mar 16, 2021 |
|
Efficacy and Safety of Anti-integrin and Sphingosine-1-Phosphate (S1P)-1 Receptor Modulators with Drs. Bruce E. Sands and William J. Sandborn
|
Mar 16, 2021 |
|
Mechanisms of Action of New Classes of Agents for Moderate to Severe Crohn’s Disease with Drs. William J. Sandborn and Bruce E. Sands
|
Mar 16, 2021 |
|
Investigational Agents in Ulcerative Colitis: IL-12 and IL-23 Inhibitors
|
Apr 29, 2019 |
|
Investigational Agents in Ulcerative Colitis: JAK Inhibitors and S1P Receptor Modulators
|
Apr 29, 2019 |
|
Investigational Agents in Ulcerative Colitis: Anti-Integrins
|
Apr 25, 2019 |
|
Ulcerative Colitis: Targeting Immunological Pathways in Moderate to Severe Disease – Updates From Copenhagen
|
Apr 25, 2019 |